Summary Information:
Ionis Pharmaceuticals Inc. Common Stock
NASDAQ:IONS


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Ionis Pharmaceuticals Inc. Common Stock
Exchange: NASDAQ
Symbol: IONS
SEC CIK: 0000874015
Phone: 7609319200
2855 GAZELLE COURT
CARLSBAD CA 92010

CEO: Brett Monia
Price when page updated: 48.815 Date: 2023-11-30
Company Website:
www.ionispharma.com

_Description: For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Its scientific innovation began and continues with the knowledge that sick people depend on it, which fuels its vision of becoming one of the most successful biotechnology companies.

IPO YEAR:

Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
7003591489.00
Beta:
1.147985319598388
52 Week High:
64.37
52 Week Low:
25.04
52 Week Change:
-0.4519101876675603
Short Interest:

Short Date:

Shares Outstanding:
141210015
Dividend Rate:
0
Dividend Yield:
10.12%
ExDividend Date:

Latest EPS:

Latest EPS Date:
N/A
Float:
0
return on Equity:
-
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
-4.22
Revenue:
N/A
Gross Profit:

Cash:

Debt:

Institution Percent:
42.95%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
-
Return on Assets:
-
Return on Capital:

Profit Margin:
-
Price to Sales:
-
Price To Book:
-
Short Ratio:
0.32
PE Ratio:
-7.7828600926567155
Employees:
757
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__Ionis Pharmaceuticals Inc. Common Stock [ IONS ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30